http://investor.alimerasciences.com/releases.cfm?sh_auth=0.0.0.ad1dcb691ef81696c0c02ea27e385165Alimera Sciences, Inc. - General Releasesen-usShareholder.com RSS Feedhttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=763656Thu, 09 May 2013 20:05:00 GMThttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=763656Alimera Sciences Reports First Quarter 2013 Financial Resultshttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=762977Wed, 08 May 2013 12:00:00 GMThttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=762977Alimera Sciences Secures $20 Million Debt Facilityhttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=762751Tue, 07 May 2013 20:01:00 GMThttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=762751Alimera Sciences Announces First Patient Treated With Commercially Available ILUVIEN®http://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=761914Fri, 03 May 2013 17:20:00 GMThttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=761914Alimera Sciences To Release First Quarter Fiscal Year 2013 Financial Resultshttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=760859Wed, 01 May 2013 12:00:00 GMThttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=760859Alimera Sciences Announces New PDUFA Date For ILUVIEN®http://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=759915Mon, 29 Apr 2013 11:30:00 GMThttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=759915Alimera Sciences Announces ILUVIEN® Now Available In U.K.http://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=750175Thu, 21 Mar 2013 20:01:00 GMThttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=750175Alimera Sciences Reports Fourth Quarter 2012 Financial Resultshttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=747141Mon, 11 Mar 2013 17:37:00 GMThttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=747141Alimera Sciences To Release Fourth Quarter And Fiscal Year 2012 Financial Resultshttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=741668Wed, 20 Feb 2013 12:30:00 GMThttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=741668Alimera Sciences Participating in Credit Suisse London One-on-One Healthcare Conferencehttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=735177Wed, 23 Jan 2013 12:30:00 GMThttp://investor.alimerasciences.com/releasedetail.cfm?ReleaseID=735177Alimera Sciences' ILUVIEN® Receives Final Published Guidance From U.K.'s NICE